MedTrace Logo

Treatment of Early Phase Achilles Tendinopathy - the Effect of NSAIDs

NCT03401177 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2020-07-09

No results posted yet for this study

Summary

this study evaluates the addition of initial short term NSAID treatment to physiotherapy prescribed exercise treatment in patient with early phase tendinopathy. Half of the participants will initially receive NSAID (naproxen) for 7 days, while the other half will receive a placebo, where after both groups will be subjected to 3 months heavy slow resistance training.

Conditions

Interventions

DRUG

Naproxen 500 Mg

Naproxen is used as a tool to dampen the inflammation thought to be present in early phase Tendinopathy

DRUG

Placebo Oral Tablet

Placebo is used, to provide a control to the active group.

OTHER

Heavy resistance training

Heavy slow resistance training - used in both groups subsequent to the initial week of NSAID or placebo treatment.

Sponsors & Collaborators

  • Bispebjerg Hospital

    lead OTHER

Principal Investigators

  • Michael Kjær, Professor · Institute of Sports Medicine, Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-15
Primary Completion
2019-07-31
Completion
2020-04-27

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03401177 on ClinicalTrials.gov